Hangzhou Tigermed Consulting Co., Ltd. Class H (DE:5HZ1)
FRANKFURT:5HZ1
Holding DE:5HZ1?
Track your performance easily

Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) Financial Statements

1 Followers

Hangzhou Tigermed Consulting Co., Ltd. Class H Financial Overview

Hangzhou Tigermed Consulting Co., Ltd. Class H's market cap is currently ―. The company's EPS TTM is €0.308; its P/E ratio is 14.12; and it has a dividend yield of 1.71%. Hangzhou Tigermed Consulting Co., Ltd. Class H is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is €0.07. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 1.68B¥ 1.81B¥ 1.78B¥ 1.82B¥ 1.82B
Gross Profit¥ 639.89M¥ 741.70M¥ 721.03M¥ 705.85M¥ 682.93M
EBIT¥ 1.24B¥ -78.82M¥ 1.06B¥ 455.10M¥ 2.77B
EBITDA¥ 1.24B¥ -78.82M¥ 1.06B¥ 455.10M¥ 2.77B
Net Income Common Stockholders¥ 401.89M¥ 412.65M¥ 673.59M¥ 518.42M¥ 1.09B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 7.88B¥ 7.78B¥ 7.81B¥ 8.02B¥ 8.57B
Total Assets¥ 27.45B¥ 27.14B¥ 25.70B¥ 24.80B¥ 23.74B
Total Debt¥ 2.80B¥ 2.87B¥ 2.41B¥ 1.77B¥ 1.19B
Net Debt¥ -5.08B¥ -4.91B¥ -5.41B¥ -6.25B¥ -7.38B
Total Liabilities-----
Stockholders Equity¥ 19.58B¥ 19.19B¥ 18.65B¥ 18.40B¥ 18.12B
Cash Flow-
Free Cash Flow¥ 406.63M¥ 339.36M¥ -77.65M¥ 240.56M¥ 595.88M
Operating Cash Flow-----
Investing Cash Flow¥ -378.72M¥ -902.46M¥ -212.64M¥ -1.30B¥ -521.28M
Financing Cash Flow¥ 15.49M¥ 356.62M¥ -95.93M¥ 533.08M¥ -16.80M
Currency in CNY

Hangzhou Tigermed Consulting Co., Ltd. Class H Earnings and Revenue History

Hangzhou Tigermed Consulting Co., Ltd. Class H Debt to Assets

Hangzhou Tigermed Consulting Co., Ltd. Class H Cash Flow

Hangzhou Tigermed Consulting Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis